| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2026―Jan―13 |
Exploration of shared gene signatures and molecular mechanisms between psoriasis and COVID-19: evidence from transcriptome data |
Rong-Jing Dong, Lu-Hui Yang, Yu-Ye Li, You-Wang Lu |
| 2 |
[GO] |
2025―Feb―22 |
New mouse model for inducible hACE2 expression enables to dissect SARS-CoV-2 pathology beyond the respiratory system |
Federica Gambini, Dominik Arbon, Petr Nickl, Vaclav Zatecka, Olha Fedosieieva, Juraj Labaj, et al. (+6) Vendula Novosadova, Jana Trylcova, Jan Weber, Jan Prochazka, Jana Balounova, Radislav Sedlacek |
| 3 |
[GO] |
2024―Nov―20 |
Impact of IL-6 rs1800795 and rs1800796 polymorphisms on clinical outcomes of COVID-19: a study on severity of disease in Turkish population |
Nilgun Cekin, Seyda Akin, Ergun Pinarbasi, Okan Halef Doğan |
| 4 |
[GO] |
2024―Nov―14 |
Investigating DNA damage caused by COVID-19 and influenza in post COVID-19 |
Elaheh Abiri, Mehdi Mirzaii, Majid Moghbeli, Amir Atashi, Ahad Ali Harati |
| 5 |
[GO] |
2024―Mar―15 |
Generation of a humanized mAce2 and a conditional hACE2 mouse models permissive to SARS-COV-2 infection |
I-Wen Song, Megan Washington, Carolina Leynes, Jason Hsu, Kempaiah Rayavara, Yangjin Bae, et al. (+11) Nele Haelterman, Yuqing Chen, Ming-Ming Jiang, Aleksandra Drelich, Vivian Tat, Denise G. Lanza, Isabel Lorenzo, Jason D. Heaney, Chien-Te Kent Tseng, Brendan Lee, Ronit Marom |
| 6 |
[GO] |
2021―Jun―04 |
SNPs at 3′UTR of APOL1 and miR-6741-3p target sites associated with kidney diseases more susceptible to SARS-COV-2 infection: in silco and in vitro studies |
Muhammad Safdar, Muhammad Sajjad Khan, Abdulkarim Yasin Karim, Shwan Ali Omar, Shukur Wasman Smail, Muhammad Saeed, et al. (+5) Sana Zaheer, Mazhar Ali, Bilal Ahmad, Muhammad Tasleem, Yasmeen Junejo |
|
